VANCOUVER, British Columbia, Aug. 15, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM.CN) (MYM.CN) (OTCBB: MYMMF) ("MYM Nutraceuticals" or the "Company") announces it has determined that the amount of biomass anticipated to be cultivated by BioHemp Naturals Growing & Farming Ltd. ("Bio Hemp") on its Sas

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- Starting in August 2019, 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, will launch "111 Insight", a video series on the development of the healthcare industry in China.The series is produced by 111,

SAN DIEGO, Aug. 15, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company, developing drugs that target cell division (mitosis), for the treatment of various cancers, including prostate, colorectal and leukemia, today announced that new clinical data from its Phase 2 trial of o

CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device Designation for its interatrial shunt for Heart Failure (HF). V-Wave's minimally invasive, impl

MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company's affiliate, Ohio Medical Solutions ("OMS"), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will be

WASHINGTON, Aug. 15, 2019 /PRNewswire/ -- The Center for Innovative GYN Care® (CIGC®) co-founders, Dr. Paul MacKou

TRACY, Calif., Aug. 15, 2019 /PRNewswire/ -- Today, e-commerce mattress and furniture company Zinus released the results of the "Sleep Anxiety America Survey," which looked at the sleep habits of over 5,000 US adults to determine whether they have become obsessed with sleep, and to ascertain the costs of this obsession—both monetary and psychological.

~Seedo's unique cultivator products join the Namaste platform and bring the benefits of growing plants into the home of global consumers~ TORONTO, Aug. 15, 2019 /PRNewswire/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced that it has signed a distribution and

SAN JOSE, Calif., Aug. 15, 2019 /PRNewswire/ -- Loop Genomics, the single molecule long-read sequencing company with a hardware free solution, has expanded its kit and services capabilities

PLYMOUTH MEETING, Pa., Aug. 15, 2019 /PRNewswire/ -- Harmony Biosciences, LLC (Harmony) announced today that the U.S. Food and Drug Administration (FDA) approved WAKIX® (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy. WAKIX is the first and only treatment approved for patients with narcolepsy that is not sch